266 related articles for article (PubMed ID: 21691261)
1. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT.
Yoshihara S; Maruya E; Taniguchi K; Kaida K; Kato R; Inoue T; Fujioka T; Tamaki H; Ikegame K; Okada M; Soma T; Hayashi K; Fujii N; Onuma T; Kusunoki Y; Saji H; Ogawa H
Bone Marrow Transplant; 2012 Apr; 47(4):508-15. PubMed ID: 21691261
[TBL] [Abstract][Full Text] [Related]
2. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
[No Abstract] [Full Text] [Related]
3. Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.
Bramanti S; Calafiore V; Longhi E; Mariotti J; Crespiatico L; Sarina B; De Philippis C; Nocco A; Santoro A; Castagna L
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1395-1406. PubMed ID: 30826463
[TBL] [Abstract][Full Text] [Related]
4. Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors.
Taniguchi K; Yoshihara S; Maruya E; Ikegame K; Kaida K; Hayashi K; Kato R; Inoue T; Fujioka T; Tamaki H; Okada M; Onuma T; Fujii N; Kusunoki Y; Soma T; Saji H; Ogawa H
Bone Marrow Transplant; 2012 Oct; 47(10):1338-42. PubMed ID: 22367345
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
6. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
Stuckey LJ; Kamoun M; Chan KM
Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
[TBL] [Abstract][Full Text] [Related]
8. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
[TBL] [Abstract][Full Text] [Related]
9. The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?
Yoshihara S; Taniguchi K; Ogawa H; Saji H
Bone Marrow Transplant; 2012 Dec; 47(12):1499-506. PubMed ID: 22231464
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
11. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
12. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
13. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation.
Kobayashi T; Maruya E; Niwa M; Saji H; Kohara S; Katayama A; Takeda A; Watarai Y; Uchida K
Hum Immunol; 2011 Jan; 72(1):11-7. PubMed ID: 20974206
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival.
Irving C; Carter V; Parry G; Hasan A; Kirk R
Pediatr Transplant; 2011 Mar; 15(2):193-7. PubMed ID: 21199210
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A
Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330
[TBL] [Abstract][Full Text] [Related]
16. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
[TBL] [Abstract][Full Text] [Related]
17. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
Lachmann N; Terasaki PI; Schönemann C
Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.
Lefaucheur C; Suberbielle-Boissel C; Hill GS; Nochy D; Andrade J; Antoine C; Gautreau C; Charron D; Glotz D
Contrib Nephrol; 2009; 162():1-12. PubMed ID: 19001809
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
20. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
Chang YJ; Luznik L; Fuchs EJ; Huang XJ
J Hematol Oncol; 2016 Apr; 9():35. PubMed ID: 27071449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]